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Abstract
Background: The repolarizing cardiac rapid delayed rectifier current, IKr, is composed of ERG1 channels. It has been
suggested that two isoforms of the ERG1 protein, ERG1a and ERG1b, both contribute to IKr. Marked heterogeneity in the
kinetic properties of native IKr has been described. We hypothesized that the heterogeneity of native IKr can be reproduced
by differential expression of ERG1a and ERG1b isoforms. Furthermore, the functional consequences of differential
expression of ERG1 isoforms were explored as a potential mechanism underlying native heterogeneity of action potential
duration (APD) and restitution.
Methodology/Principal Findings: The results show that the heterogeneity of native IKr can be reproduced in heterologous
expression systems by differential expression of ERG1a and ERG1b isoforms. Characterization of the macroscopic kinetics of
ERG1 currents demonstrated that these were dependent on the relative abundance of ERG1a and ERG1b. Furthermore, we
used a computational model of the ventricular cardiomyocyte to show that both APD and the slope of the restitution curve
may be modulated by varying the relative abundance of ERG1a and ERG1b. As the relative abundance of ERG1b was
increased, APD was gradually shortened and the slope of the restitution curve was decreased.
Conclusions/Significance: Our results show that differential expression of ERG1 isoforms may explain regional
heterogeneity of IKr kinetics. The data demonstrate that subunit dependent changes in channel kinetics are important
for the functional properties of ERG1 currents and hence IKr. Importantly, our results suggest that regional differences in the
relative abundance of ERG1 isoforms may represent a potential mechanism underlying the heterogeneity of both APD and
APD restitution observed in mammalian hearts.
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Introduction
The molecular correlate of the cardiac rapid delayed rectifier
current, IKr, is the ERG1 (Kv11.1) ion channel [1,2]. Mutations in
the human variant of ERG1 (hERG1) has been linked to the long
QT [3] and short QT syndromes [4]. Two isoforms of ERG1,
ERG1a and ERG1b, have been detected on the protein level in
both rat, canine and human cardiac tissue [5]. The isoforms differ
only in the N-terminal region. Compared to ERG1a, the N-
terminus of ERG1b is 340 amino acids shorter. However, the
initial 36 residues of ERG1b are unique to this isoform [6,7].
Quantification of mRNA from healthy human hearts have shown
that hERG1b accounts for 10–20% of the total hERG1 transcripts
[8]. Very recently, a mutation in the unique N-terminus of
hERG1b was discovered in a patient with long QT syndrome [9]
highlighting the importance of this isoform in cardiac repolariza-
tion. However, little is known about regional differences in the
relative abundance of hERG1a and hERG1b or the potential
functional consequences thereof.
Gintant [10] used voltage ramps to characterize IKr transients in
isolated canine cardiomyocytes. The IKr transient showed only
little variation in the peak current density but a large variation
(20–30 mV) in the membrane potential at which the current
peaked. This variation in ‘peak potential’ was evident in both
atrial, ventricular and purkinje fiber cells. These observations
suggest that the kinetic properties of IKr are different between
individual cardiac cells. Theoretically, in terms of ERG1 channel
gating, differences in kinetics of recovery from inactivation and
kinetics of deactivation could explain such a variation in ‘peak
potential’. Interestingly, it has been shown that the deactivation
rate of IKr is faster in epicardial than in midmyocardial cells
obtained from canine left ventricular muscle [11] supporting that
regional differences in the kinetics of IKr exist in mammalian
hearts.
In heterologous expression systems, heteromeric ERG1a/b,
homomeric ERG1a and homomeric ERG1b channels differ in
their kinetic properties [6,8,9,12]. Potentially, by varying the
relative abundance of ERG1 isoforms, the macroscopic kinetics of
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hypothesized that the variation in ‘peak potential’ of the IKr
transient observed in native cardiac cells [10] can be explained by
differences in macroscopic channel kinetics caused by a variation
in the relative abundance of ERG1 isoforms. As the functional
consequences of regional differences in the relative abundance of
ERG1 isoforms are largely unknown we explored this as a
potential mechanism underlying native heterogeneity of action
potential characteristics.
We find that the characteristics of native IKr transients can be
reproduced in heterologous expression systems by differential
expression of hERG1a and hERG1b isoforms. Furthermore, we
describe how differential expression of hERG1a and hERG1b




cDNAs encoding hERG1a (acc. number NM_000238) and
hERG1b (acc. number NM_172057) were inserted into either
pcDNA3 (for mammalian expression) or into pXOOM [13] (for
expression in X. laevis oocytes) plasmids. The hERG1b clone was
obtained from A. Arcangeli (Universita ` degli Studi di Firenze,
Italy).
Expression in HEK293 Cells
HEK293 cells were maintained in DMEM (Invitrogen,
Carlsbad, CA, USA) supplemented with 10% fetal bovine serum
and 5% CO2 at 37uC. At 50–60% confluency, cells were
transiently transfected with a total of 2 mg of cDNA using
Lipofectamine (Invitrogen, Carlsbad, CA, USA) according to the
manufacturer’s instructions. For co-transfection, 1 mg of each
cDNA was used. 0.3 mg of eGFP in pcDNA3 was co-transfected to
identify successfully transfected cells. 48 hours after transfection,
the cells were trypsinized and transferred to cover slips for
experiments.
Expression in X. laevis Oocytes
cRNA for injection was prepared from the linearized DNA
constructs using the T7 m-Message Machine kit (Ambion, Austin,
TX, USA) according to the manufacturer’s instructions. RNA
concentrations were quantified using a Nanodrop ND-1000
spectrophotometer (NanoDrop Technologies, Wilmington, DE,
USA) and RNA quality was checked by gel electrophoresis. X.
laevis oocytes were either purchased from Ecocyte Bioscience
(Castrop-Rauxel, Germany) or prepared in-house. In the latter
case X. laevis surgery and oocyte treatment were performed
according to the guidelines of the Danish National Committee for
Animal Studies. For co-expression of hERG1a and hERG1b
cRNAs were mixed in different molar ratios (20%, 40%, 60% and
80% hERG1b) before injection. After injection the oocytes were
kept in Kulori solution (in mM: 87 NaCl, 4 KCl, 1 MgCl2,1
CaCl2, 5 HEPES, pH 7.4) at 19uC for 2–3 days before
experiments were performed.
Electrophysiological Procedures
Measurements on HEK293 cells were performed in the whole-
cell patch clamp configuration using an EPC-9 patch clamp
amplifier (HEKA Elektronik, Lambrecht/Pfalz, Germany). The
glass pipettes for the recording electrodes had a tip resistance of
1.5–2.5 MOhm when filled with intracellular solution. The series
resistance recorded in the whole-cell configuration was 2–8
MOhm and was compensated (80%). The extracellular solution
contained (in mM): NaCl 140, KCl 4, CaCl2 2, MgCl2 1 and
HEPES 10, pH 7.4. The intracellular solution used in the pipettes
contained (in mM): KCl 110, EGTA 10, CaCl2 5.17, MgCl2 1.42,
K2ATP 4, HEPES 10, pH 7.2.
Measurements on X. laevis oocytes were performed with the two-
electrode voltage-clamp technique using a Dagan CA-1B amplifier
(Dagan Corporation, Minneapolis, MN, USA). The recordings
were performed under continuous superfusion with Kulori
solution. The glass pipettes for the recording electrodes were
filled with 2 M KCl and had tip resistances of 0.5–2.5 MOhm.
All recordings were performed at room temperature and data
was acquired using the Pulse software (HEKA Elektronik,
Lambrecht/Pfalz, Germany). The time constant of activation at
0 mV was determined using the standard envelope of tails
protocol, measuring the peak tail current at either 260 mV or
2100 mV. A single-exponential function was fitted to the
normalized peak tail currents to obtain tact. The time constants
of channel deactivation (tslow and tfast) were obtained by fitting a
double-exponential function to tail current traces measured at
260 mV following a voltage step to +20 mV for 1000 ms to
achieve maximal activation. Similarly, the time constant of
recovery from inactivation (trec)a t260 mV was determined from
the initial rising phase of the tail currents recorded with this
protocol. The extrapolated fit of the deactivation process was
subtracted from the initial rising phase of the tail currents. The
difference between the extrapolated values and the recorded
current values represents the time course of recovery from
inactivation. The time constant of this process was estimated by
fitting a single-exponential function to the resulting curve. Please
see the Results section and figure legends for details on the voltage
ramp protocols. For all protocols, the holding potential was
280 mV.
Computational Modeling
All simulations were performed using the COR program [14].
The built-in CVODE integrator was used with a time step of
0.01 ms. All models were encoded in CellML 1.0 (http://www.
cellml.org/).
We adopted the Markov model formulation of hERG1 as
described by Fink et al. [15]. The model includes three closed
states (C1-C3), an open state (O) and an inactivated state (I). The
topology of the model is shown in figure 1. The model has been
shown to reproduce data recorded both at room temperature and
at physiological temperature reasonably well. The hERG1
Markov simulations were performed at 296 K with 4 mM
extracellular potassium. In our simulations we modified the
transition rate of activation a3 (transition from the closed state
C3 to the open state O), the transition rate of deactivation b3
(transition from the open state O to the closed state C3) and the
transition rate of recovery from inactivation b4 (transition from the
inactivated state I to the open state O).
For single cell action potential (AP) simulations we used the ten
Tusscher model (TT) of the human ventricular epicardial cell [16].
Figure 1. Topology of the hERG1 Markov model. The hERG1
Markov model developed by Fink et al. [15], consists of three closed
states (C1-C3), an open state (O) and an inactivated state (I). Allowed
transitions between states are indicated with arrows. The transition
rates are indicated above or below the corresponding transitions.
doi:10.1371/journal.pone.0009021.g001
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www.cellml.org/models/tentusscher_panfilov_2006_version04) on
the 11
th of April 2009 (Note: after the model was down-
loaded the CellML website has been restructured and the model
can now be found at http://models.cellml.org/exposure/
de5058f16f829f91a1e4e5990a10ed71). This version of the model
has reached curation level 2 indicating that it qualitatively
reproduces the results published in the original paper (see
http://www.cellml.org/repository-info/info for details on the
curation procedure). We exchanged the original Hodgkin-Huxley
formulation of IKr for the hERG1 Markov model described above
[15]. In the modified model (TTF) we adjusted GKr,max by a factor
of 0.3 to 0.046 nS/pF. Otherwise, no changes were made to the
downloaded model. To ensure steady-state conditions the
ventricular cell model was paced at a basic cycle length (BCL)
of 1000 ms for 500 beats prior to any modification of hERG1
kinetics. After the kinetic modifications the models were paced
for another 100 beats (BCL 1000 ms) to ensure that a new steady-
state was reached. APD restitution was determined using the
standard S1-S2 protocol. After reaching steady-state (BCL
1000 ms) a premature stimulus (S2) was introduced at progres-
sively shorter diastolic intervals (DI). The APD restitution curve
was obtained by plotting APD against the preceding DI. A single-
exponential function was fitted to each restitution curve and the
slope was calculated by differentiation of the fitted curve.
Data Analysis
Data analysis was performed with Igor Pro (Wavemetrics, Lake
Oswego, OR, USA), GraphPad Prism (GraphPad Software Inc.,
San Diego, CA, USA) and R (http://www.R-project.org)
software. Statistical comparisons were performed using ANOVA
followed by Tukey’s procedure or an appropriate set of custom-
defined contrasts. A P-value of less than 0.05 was considered
statistically significant. Unless otherwise stated, data are repre-
sented as mean 6 SEM.
The electrophysiological experiments were not designed to
compare the absolute current levels between hERG1a and
hERG1b channels. In order to compare data independently of
differences in transfection efficiency and/or translation/trafficking
processes, we normalized the current levels to a value (N)
proportional to the number of expressed channels as described
by Sale et al. [9]. Briefly, we subjected cells/oocytes to a
depolarizing voltage step to +40/+20 mV for 1000 ms to achieve
maximal activation of hERG1 channels followed by a step to
260 mV for 3 s to record channel deactivation. A double-
exponential function was fitted to the current decay at 260 mV.
By extrapolation back to the beginning of the 260 mV voltage
step we obtained an estimate of N. This normalization is valid
under the assumption that the single channel conductances are
identical. It has been shown, that for hERG1a single channel
conductance does not depend on the length of the N-terminus
[17]. As the only difference between hERG1a and hERG1b is the
N-termini the assumption seems justified.
Results
Differential Expression of hERG1a and hERG1b Modulates
the ‘Peak Potential’
In order to address whether differential expression of hERG1a
and hERG1b was able to modulate the ‘peak potential’, i.e. the
potential where the current peaks during a repolarizing voltage
ramp, we transfected HEK293 cells with either hERG1a,
hERG1b or both channel subunits. The cells were clamped at
+40 mV for 200 ms to activate the channels and then repolarized
to 280 mV using a ramp with a slope of 20.12 mV/ms.
Representative currents recorded during the ramp are shown in
figure 2A. Currents were normalized to the maximum peak
current for comparison. The data show that expression of
hERG1b was able to shift the ‘peak potential’ significantly towards
more depolarized potentials. Summary data are shown in
figure 2B. To compare peak amplitudes independently of
expression levels data was normalized to a value, N, proportional
to the number of expressed channels (see Methods for details). For
hERG1a channels the ‘peak potential’ was 239.661.7 mV, for
hERG1a/b channels it was shifted to 219.362.9 mV and for
hERG1b channels it was 1.961.9 mV (P,0.05 for all compar-
isons). The peak amplitudes, normalized to N, were 0.3960.01
Figure 2. The relative abundance of hERG1a and hERG1b
determines the ‘peak potential’ in mammalian cells. A,
Representative recordings of hERG1a, hERG1b and hERG1a/b channels
expressed in HEK293 cells are shown. Currents were recorded using the
protocol depicted in the inset. Only currents recorded during the ramp
are shown. For comparison, currents were normalized to the maximum
peak current during the ramp and plotted against the command
voltage. The dotted lines indicate the potential where the currents
peaked (‘peak potential’) and are also used to indicate the expressed
channels. B, Summary data of the variation in ‘peak potential’. For
comparison, the peak amplitude was normalized to an estimate of the
number of channels (N) and plotted as a function of the ‘peak
potential’.
doi:10.1371/journal.pone.0009021.g002
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hERG1a) and 0.3760.01 (hERG1b).
To verify the relationship between ‘peak potential’ and relative
abundance of hERG1b we repeated the experiment in X. laevis
oocytes. In the oocyte expression system, cRNA is injected directly
into the oocytes and hence, the relative amounts of cRNA can be
controlled very precisely. In figure 3A currents recorded from
oocytes injected with different ratios of hERG1a and hERG1b
(indicated as % of hERG1b abundance) are shown. The voltage
protocol and normalization of data are identical to what is
described above for figure 2A. The data show that as the relative
abundance of hERG1b was increased, the ‘peak potential’ was
gradually shifted towards more depolarized potentials, demon-
strating that there was indeed a very good correlation between the
‘peak potential’ and the relative abundance of hERG1b. The
results of the oocyte experiments are summarized in figure 3B.
The ‘peak potentials’ were 242.661.1 mV (hERG1a; 0%
hERG1b), 232.360.8 mV (20% hERG1b), 225.461.1 mV
(40% hERG1b), 221.261.6 mV (60% hERG1b), 217.861.3
(80% hERG1b) and 213.860.6 mV (100% hERG1b) (P,0.05
for all comparisons except for 60% vs. 80% hERG1b and 80% vs.
100% hERG1b). When normalized to N there was no significant
variation in the peak amplitude. The values were 1.1760.03
(hERG1a; 0% hERG1b), 1.1660.02 (20% hERG1b), 1.2160.03
(40% hERG1b), 1.2760.05 (60% hERG1b), 1.2960.04 (80%
hERG1b) and 1.2760.03 (100% hERG1b).
Macroscopic Kinetics of hERG1 Channels Are Dependent
on the Relative Abundance of hERG1a and hERG1b
Previously, it has been shown that hERG1a and hERG1b
channels vary in kinetics of activation, deactivation and recovery
from inactivation, i.e. the rates are increased by hERG1b, whereas
no change in inactivation kinetics are observed.[8,9] To further
verify our hypothesis we determined the kinetics of activation,
deactivation and recovery from inactivation for hERG1 channels
expressed in X. laevis oocytes using the same ratios of hERG1a to
hERG1b as described above. In table S1 the time constants of
these processes are given. Based on the average values, the relative
changes in the time constants were calculated (table S1).
Interestingly, linear correlations could be obtained for the relative
changes in both tfast (r
2=0.95), tslow (r
2=0.99) and trec (r
2=0.94)
as a function of injected hERG1b cRNA (figure S1A-C). It was not
possible to obtain a reliable estimate of trec for hERG1b channels
alone due to a significant overlap with the transient capacitative
current. Instead, the relative change in trec for hERG1b compared
to hERG1a was calculated by extrapolation from the linear fit over
the range 0–80% hERG1b (figure S1C). In contrast to tfast and
trec the relative change in the time constant of activation was not
linear. Rather, with the exception of 40% hERG1b the time
constant was increased by approximately 1.5 fold for all ratios
compared to hERG1a alone (figure S1D). For 40% hERG1b the
time constant of activation was increased almost 2-fold. However,
statistical analysis showed that although significantly different from
hERG1a (0% hERG1b, P,0.05 for all comparisons) the time
constants of activation for 20–100% hERG1b were not signifi-
cantly different from each other.
The possibility exists, that the intermediate kinetics observed in
co-injected oocytes could arise from a channel population
consisting of a mixture of distinct homomeric hERG1a and
hERG1b channels. To address this issue, the observed tail currents
recorded using the deactivation protocol from oocytes injected
with 20–80% hERG1b were compared with the expected
theoretical current decay assuming the formation of only
homomeric channels. Averages of the observed current decay for
20–80% hERG1b were calculated using the corresponding fitted
time constants and their relative weights (table S1). The theoretical
current decay was calculated as a weighted algebraic summation
of the deactivation kinetics of hERG1a and hERG1b homomeric
channels. Figure S2 shows the normalized decay of both the
observed and theoretical situation at the four different isoform
ratios. For all four comparisons, the (averaged) observed currents
decay faster than the theoretical curves. Thus, the observed
currents can not be explained by the presence of homomeric
channels only. Similarly, the finding that the relative increase in
activation kinetics did not change gradually as the relative
abundance of hERG1b cRNA was increased also argues that
the channel population upon co-expression of hERG1a and
Figure 3. The ‘peak potential’ is directly dependent on the
relative abundance of hERG1 isoforms. A, Representative record-
ings from X. laevis oocytes injected with different ratios of hERG1
isoforms. The same protocol as shown in figure 2A was used. Only
currents recorded during the ramp are shown. For comparison, currents
were normalized to the maximum peak current during the ramp and
plotted against the command voltage. The dotted lines indicate the
potential where the currents peaked (‘peak potential’) and are also used
to indicate the isoform ratio (in % of hERG1b abundance). B, Summary
data of the variation in ‘peak potential’. For comparison, the peak
amplitude was normalized to N and plotted as a function of the ‘peak
potential’.
doi:10.1371/journal.pone.0009021.g003
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separate pools of homomeric hERG1a and hERG1b channels.
A hERG1 Markov Model Reproduces the Experimental
Data
The Markov model of hERG1, developed by Fink et al. [15], is
able to reproduce hERG1 currents recorded both at room
temperature as well as at physiological temperature. The relative
changes in kinetics determined from the oocyte experiments
reflecting different ratios of hERG1a and hERG1b were
incorporated into the Markov model to investigate whether the
model could reproduce the experimental findings. The factors by
which the rate constants were changed are given in table S2. Like
most hERG1 Markov models, the present model uses a single-
exponential function to describe the transition from the open to
the first closed state (O to C, transition rate b3) while the
deactivation process experimentally is most commonly best fit with
a double-exponential function. Changes in the model deactivation
kinetics were based on the relative changes in the fast component
of deactivation obtained from the experiments. The model was
subjected to the same voltage clamp protocol that was used in the
in vitro experiments (see inset in Figure 2A). The resulting
simulated currents are shown in figure 4A. Increasing the rate
constants of activation, deactivation and recovery from inactiva-
tion by the same factors as obtained from the oocyte experiments
gradually shifted the ‘peak potential’ from 248.4 mV (represent-
ing hERG1a) to 228.4 mV (representing hERG1b). The overall
shape of the currents were very similar to the recordings obtained
for hERG1 channels expressed in both mammalian cells and
oocytes (compare figure 4A to figures 2A and 3A). The peak
amplitude is plotted against the ‘peak potential’ in figure 4B. The
changes in peak amplitude followed a pattern similar to the one
observed in the oocyte experiments (compare to figure 3B).
Action Potential Characteristics Are Modulated by the
Relative Abundance of hERG1a and hERG1b
To examine the potential functional effects of changes in the
relative abundance of hERG1a and hERG1b on the cellular level
we substituted the original Hodgkin-Huxley formulation of IKr in
the TT model of the human ventricular cardiomyocytes [16] for
the Fink Markov model of the hERG1 current. We refer to the
modified model as TTF. After adjustment of the maximum
conductance of IKr (GKr,max) there were only minor differences in
the shape of IKr when comparing the two models (data not shown).
Steady-state APD90 (BCL 1000ms) was 303 ms and 302 ms for the
TT and the modified TTF models respectively.
As before, the hERG1 Markov model was modified to reflect
the different ratios of hERG1a and hERG1b based on the factors
given in table S2. Steady-state action potentials (BCL 1000 ms) are
shown in figure 5A. As the relative abundance of hERG1b was
increased the APD90 was gradually shortened from 302 ms
(hERG1a) to 275 ms (hERG1b). For 20, 40, 60 and 80% hERG1b
the APD90 was 292, 285, 285 and 279 ms respectively. In figure 5B
the IKr corresponding to the action potentials in figure 5A are
shown. The IKr peaked earlier and the peak amplitude became
greater as the relative abundance of hERG1b was increased.
Figures 5C and D show the proportion of channels in the open
and inactivated states respectively during the action potential. The
increase in recovery rate allowed the channels to escape the
inactivated state earlier during the action potential (figure 5D).
Although the maximum proportion of channels in the open state
was decreased as the relative abundance of hERG1b was increased
(figure 5C) the driving force on these channels were much greater
due to the more depolarized membrane potential at this earlier
phase resulting in the increased IKr amplitude. The shortening of
APD in response to greater abundance of hERG1b is therefore
mainly due to the increase in recovery rate.
The TT model has been shown to reproduce data on human
restitution kinetics [16]. We wanted to know whether the changes
in transition rates would also affect the restitution properties.
Action potential restitution was measured using a standard S1-S2
protocol. At steady-state pacing (BCL 1000 ms) an additional
stimulus (S2) was introduced at successively shorter coupling
intervals and the corresponding APD90 was determined. The
relationship between APD90 and DI could be described by a
Figure 4. The experimental data is reproduced by a hERG1
Markov model. A, The effect of changes in transition rates,
representing a gradual increase in the relative abundance of hERG1b,
on simulated hERG1 currents. The transition rates of hERG1 channel
activation (a3), deactivation (b3) and recovery from inactivation (b4)
were modified to represent a gradual increase in the relative abundance
of hERG1b (see table S2 for details). The model was subjected to the
same voltage protocol as in figure 2A. Only currents recorded during
the ramp are shown. For comparison, currents were normalized to the
maximum peak current during the ramp and plotted against the
command voltage. The dotted lines indicate the potential where the
currents peaked (‘peak potential’) and are also used to indicate the
isoform ratio (in % of hERG1b abundance). B, The variation in ‘peak
potential’ amplitude is shown as a function of ‘peak potential’. The data
were not normalized as the number of channels in the model remained
constant.
doi:10.1371/journal.pone.0009021.g004
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curves are shown. For simplicity the exponential fits are not
shown. As the relative abundance of hERG1b was increased the
restitution curves became gradually flatter. The slope of the
restitution curve is associated with electrical stability of cardiac
tissue. To study the slope of the curves in more detail, the
exponential fits to the restitution curves were differentiated to
obtain the slope over the whole range of DIs. The relationships
between slope and DI are shown in figure 6B. The figure shows
that as the relative abundance of hERG1b was increased the slope
of the restitution curve was reduced markedly for DIs shorter than
200 ms. In general, the slope of the restitution curve is dependent
on the balance between inward and outward currents immediately
before the S2 stimulus is applied. Mechanistically, the reduced
slope can therefore be explained by fewer hERG1 channels
residing in the open state during late phase 3 and phase 4 of the
action potential (figure 5C). Thus, the change in restitution slope is
mainly due to the increase in deactivation kinetics resulting from
greater hERG1b abundance.
Discussion
A considerable variation has been observed in the ‘peak
potential’ characterizing native IKr transients [10]. This observa-
tion may, in theory, be explained by differences in IKr channel
kinetics. Intrinsic differences in IKr deactivation kinetics have been
described [11] supporting the notion that considerable heteroge-
neity in IKr kinetics exists in the heart.
Figure 5. Action potential duration is modulated by the relative
abundance of hERG1a and hERG1b. A, Steady-state action potentials
simulated by the modified ten Tusscher (TTF) model paced at a basic
cycle length (BCL) of 1000 ms. The transition rates of hERG1 channel
activation (a3), deactivation (b3) and recovery from inactivation (b4)w e r e
modified to represent a gradual increase in the relative abundance of
hERG1b (see table S2 for details). B, Simulated IKr corresponding to the
action potentials shown in A. Legend is the same as in A. C and D,
Channel state occupancy during the action potential is shown for the
open and inactivated states respectively. Legend is the same as in A.
doi:10.1371/journal.pone.0009021.g005
Figure 6. Restitution slope is modulated by the relative
abundance of hERG1a and hERG1b. A, Single-cell action potential
restitution. The restitution curves were obtained using an S1-S2
restitution protocol measured at a BCL of 1000 ms. The action potential
duration (APD90) is plotted as a function of the diastolic interval (DI).
The transition rates of hERG1 channel activation (a3), deactivation (b3)
and recovery from inactivation (b4) were modified to represent a
gradual increase in the relative abundance of hERG1b (see table S2 for
details). B, The slopes of the restitution curves were calculated by
differentiation of single-exponential functions fitted to the curves in A
and plotted as a function of DI.
doi:10.1371/journal.pone.0009021.g006
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Properties of IKr Transients
We hypothesized that the observed variation in ‘peak potential’
of the native IKr transient [10] could be explained by variation in
kinetic rates as a result of differential expression of ERG1 isoforms.
Indeed, by varying the relative abundance of hERG1a and
hERG1b we were able to manipulate the ‘peak potential’ over a
wide range of potentials. We were able to do this in both
mammalian cells and in X. laevis oocytes. In oocytes, where we
could control the exact ratio of the two isoforms the ‘peak
potential’ showed a very good correlation to the relative
abundance of the isoforms. The differences in the absolute values
of ‘peak potentials’ and peak amplitudes between ERG1 channels
expressed in mammalian cells and in oocytes may be attributed to
differences in the expression systems.
Compared to hERG1a channels, increased rates of both
activation, deactivation and recovery from inactivation have been
described for heteromeric hERG1a/b channels [8,9]. We were
able to show that the relative changes in the kinetics of
deactivation and recovery from inactivation is a linear function
of the relative hERG1b abundance in X. laevis oocytes.
Interestingly, a similar relationship was not obtained for the
process of activation. The reason for the non-linear relationship
between activation kinetics and isoform abundance is beyond the
scope of this study. However, it is worth noting that when
expressed in CHO cells hERG1a/b channels display deactivation
and recovery kinetics intermediate of those of hERG1a and
hERG1b homomeric channels while activation kinetics of
hERG1a/b are similar to hERG1b [8]. hERG1 channels are
believed to be tetramers. Possibly, the number of long 1a-type N-
terminals in the channel complex may play a crucial role in the
activation process. Future studies focusing on molecular determi-
nants of gating characteristics of heteromeric channels may
explain these findings. Nevertheless, the systematic changes in
kinetics of deactivation and recovery as a function of hERG1b
abundance explain the variation in ‘peak potential’.
The absolute variation in the ‘peak potential’ observed by
Gintant [10] in canine cardiomyocytes (20–30 mV) is within the
range observed in our experiments (,40 mV in HEK293 cells and
,30 mV in X. laevis oocytes). Although there were differences in
the experimental conditions, the data suggest a large variation in
the relative abundance of ERG1a and ERG1b in native
cardiomyocytes. However, our results show that the ‘peak
potential’ of hERG1 channels in general occurs at more
depolarized potentials as compared to the data from canine
cardiomyocytes [10]. This difference can not be fully explained by
differences in the temperature at which the data was obtained. It
may, however, partly be attributed to species-dependent differ-
ences in IKr kinetics (see [18] for review). IKr is known to deactivate
slower in canine than in human cardiomyocytes [18]. Thus, the
‘peak potential’ is expected to occur at more depolarized potentials
for human ERG1 channels. Interestingly, Hua et al. [19] have
shown that over-expression of hERG1a by adenoviral transfection
in isolated canine cardiomyocytes shifted the ‘peak potential’
towards more depolarized potentials as compared to control.
Additionally, differences in post-translational modifications of
hERG1 channels and/or interactions with auxiliary proteins may
play a role [18].
When we normalized the recorded currents to a value
proportional to the number of expressed channels, we observed
only little variation in the peak current density over the whole
range of isoform ratios in both expression systems. Similarly,
Gintant [10] reported only small variations in the absolute IKr
peak density. Although speculative, taken together these data
may indicate that the absolute number of ERG1 channels in the
membrane of cardiomyocytes is relatively constant from cell to
cell but that the relative abundance of ERG1a and ERG1b
varies.
We have based our study on a comparison of canine IKr [10]
and heterologously expressed hERG1a and hERG1b channels.
Although our results qualitatively show that differential expression
of hERG1a and hERG1b may explain the observed variation in
canine IKr, it remains to be shown to which extend post-
translational modifications and/or interactions with auxiliary
proteins influence the properties of native IKr. Also, it is unknown
whether a similar variation is present in the human heart. Given
the relatively high abundance of hERG1b in the human heart
[5,8] it seems plausible to suggest that at least some degree of
variation is present. Interestingly, the existence of separate
promoter regions for hERG1a and hERG1b has been described
[20] providing a potential mechanism for such differences.
Therefore, differences in the relative abundance of hERG1a and
hERG1b may underlie regional heterogeneity of IKr kinetics.
Future studies looking into these issues are needed to fully establish
the importance of ERG1b in the human heart. To this end, our
results suggest that it is the relative (to ERG1a) rather than the
absolute abundance of ERG1b that determines the properties
of IKr.
Functional Implications of ERG1b in the Heart
To address the possible functional implications of differential
expression of hERG1a and hERG1b in the heart we conducted a
series of computer simulations. First, we used a previously
published hERG1 Markov model [15] to reproduce the
experimental data. In our simulations we changed the kinetic
rates of the Markov model by factors corresponding to the relative
changes in kinetics observed in the in vitro experiments.
Qualitatively, the model reproduced the experimental data well,
especially considering that the intrinsic kinetics of the model were
somewhat different than the experimental observations (single vs.
double-exponential kinetics of deactivation). Second, the Markov
model was introduced into the TT model of the ventricular
cardiomyocyte. The results of the ventricular cardiomyocyte
simulations showed that kinetic changes in IKr corresponding to
increases in the relative abundance of hERG1b resulted not only
in gradually shorter steady-state APD but also in flatter restitution
curves. Mechanistically, inspection of the changes in channel state
occupancy revealed that the shortening of APD was mainly due to
the increase in recovery rate. Similarly, the decrease in restitution
slope was mainly a result of the increase in deactivation rate.
The existence of a transmural APD gradient has been well
established and has been attributed to differences in IK density
[21–23]. Our results show that differences in IKr kinetics,
especially differences in kinetics of recovery from inactivation,
may also contribute to APD dispersion. It is therefore interesting to
note that in the study by Szabo et al. [11] the shortest APDs were
recorded in the epicardial cells where also the deactivation kinetics
of IKr were fastest. Assuming that faster deactivation rate is due to
greater relative abundance of ERG1b, IKr in these cells would be
expected also to display a faster rate of recovery from inactivation.
In our simulations such differences are predicted to shorten APD,
suggesting that differences in IKr kinetics may indeed contribute to
the APD dispersion observed in vivo.
APD restitution describes the relationship between APD and
DI. When the slope of the restitution curve is steep, APD is very
sensitive to even small changes in DI and as a result APD alternans
may develop. Accordingly, steep restitution slopes has been
associated with an increased risk of ventricular fibrillation
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between different regions of the heart [27–29]. Although
restitution heterogeneity has been described in the normal heart
[27], increased heterogeneity may provide a substrate for
arrhythmia in diseased hearts [29]. The mechanism of APD
restitution is complex and likely involves several factors.
Previously, the relative densities of IKr and IKs have been
implicated in determining restitution slope [30,31]. Also, calcium
dynamics are involved as blockade of L-type calcium channels
flatten restitution [26]. Our results suggest that also differences in
the intrinsic kinetics of IKr resulting from variation in the relative
abundance of hERG1a and hERG1b may play a role.
In summary, the results suggest that by modulating the relative
expression of ERG1a and ERG1b, a given cell can control the
kinetics of IKr resulting in modulation of both APD and the slope
of the restitution curve. The results show that cells with a low
relative abundance of ERG1b will have relatively long baseline
APD and steep restitution slopes. Cells with a high relative
abundance of ERG1b will have shorter baseline APD and less
steep restitution slopes. Interestingly, a similar relationship
between baseline APDs and restitution kinetics have been
observed in native cardiac cells [27,32]. Thus, the predicted effect
of regional variation in the relative abundance of ERG1a and
ERG1b agree well with existing findings in cardiac tissue. As such,
regional differences in the relative abundance of ERG1a and
ERG1b may represent a potential mechanism underlying the
heterogeneity observed in both APD and APD restitution kinetics.
This is, to our knowledge, the first time that intrinsic variation in
IKr kinetics has been suggested to play a role in heterogeneity of
APD restitution. However, as this association is based on indirect
evidence from heterologous expression and computational mod-
eling experiments, more studies examining the relationship
between the relative abundance of ERG1 isoforms and restitution
kinetics in cardiac tissue are needed to determine if this predicted
association is also evident in vivo.
In conclusion, our results show that differential expression of
hERG1a and hERG1b can reproduce the observed variation in
the characteristics of native IKr. Thus, based on a functional
comparison between heterologously expressed hERG1 channels
and native IKr, the results demonstrate that variations in the
relative abundance of ERG1 isoforms are likely present in the
heart. Computer simulations suggest that differences in the
relative abundance of hERG1a and hERG1b translate into
differences in APD and APD restitution on the cellular level.
Consequently, we propose that differences in the relative
abundance of hERG1a and hERG1b may represent a potential
mechanism underlying regional heterogeneity of both APD and
APD restitution observed in mammalian hearts. Our results add
to the growing body of evidence that ERG1b contributes
significantly to the generation of cardiac IKr and plays an
important role in cardiac electrophysiology.
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Found at: doi:10.1371/journal.pone.0009021.s001 (0.10 MB
PDF)
Table S2
Found at: doi:10.1371/journal.pone.0009021.s002 (0.08 MB
PDF)
Figure S1 Correlation between macroscopic channel kinetics
and isoform abundance. The relative change in the kinetic
parameters of deactivation (A, fast component; B, slow compo-
nent), recovery from inactivation (C) and activation (D) as
compared to hERG1a (0% hERG1b) was calculated based on
the values in table S1 and plotted as a function of hERG1b cRNA
abundance. The solid lines indicate the linear correlations. The
correlation coefficients are also shown. In C, the dotted line and
the open square indicate the extrapolated value for hERG1b.
Found at: doi:10.1371/journal.pone.0009021.s003 (0.26 MB TIF)
Figure S2 Comparison of deactivation kinetics for observed and
theoretical currents. A-D, Calculations of observed and theoretical
time course of current decay are shown for different relative
abundances of hERG1b as indicated. The observed current decay
(Exp, solid lines) in each situation was calculated from the
observed macroscopic deactivation properties (table S1). The
theoretical current decay (Theory, dotted lines) was calculated
under the assumption that only hERG1a and hERG1b channels
were formed. Notice that for all comparisons the observed currents
decay faster than the theoretical predictions.
Found at: doi:10.1371/journal.pone.0009021.s004 (0.30 MB TIF)
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